Breast Test Wales Screening Division Public Health Wales

Similar documents
BSA New Zealand Hawkes Bay District Health Board Coverage Report

APPENDIX ONE. 1 st Appointment (Non-admitted) recovery trajectories

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

Cancer Alliance Data Pack

Using Cancer Registration and MDT Data to Provide Information on Recurrent and Metastatic Breast Cancer

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

Cancer Alliance Data Pack

Clostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:

FAQs about Provider Profiles on Breast Cancer Screenings (Mammography) Q: Who receives a profile on breast cancer screenings (mammograms)?

Pennine Acute Hospitals NHS Trust. Advancing Quality Results October 2008 to December 2016

PERFORMANCE AGAINST IMMUNISATION TIER 1 TARGETS

March 2012: Next Review September 2012

Has the UK had a double epidemic?

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

NHS WALES PRIMARY CARE PRESCRIBING ANALYSIS FOR TRAMADOL DATA TO SEPTEMBER 2014

UPDATE REPORT: POPULATION SCREENING PROGRAMMES IN POWYS. This is a briefing report on the delivery of population screening in Powys

Swine Flu Pandemic Weekly Report Thursday 20 August 2009

RTT Exception Report

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

The PROMs Programme in the NHS in England

Quit Rates of New York State Smokers

Analysis of Meter Reading Validation Tolerances proposed by Project Nexus

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

FALL RISK REDUCTION AT THE OTTAWA HOSPITAL WORKING TOGETHER TOWARDS BEST PRACTICE

Magellan s Transport Route Lead Monitoring Program

Brighton and Sussex University Hospitals NHS Trust Board of Directors. Mark Smith Chief Operating Officer

Strengthening Health Systems for an AIDS-Free Generation 4th Annual IAS/IAC Pre-conference Meeting WASHINGTON, DC JULY 20-21, 2012

Key statistics from the National Cardiac Arrest Audit: Paediatric arrests April 2012 to March 2017

NHS Breast Cancer Screening Programme.

NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN

Quarterly Dialysis Facility Compare - Preview for April 2018 Report DFC Dialysis Facility State: XX Network: 99 CCN: SAMPLE

Curators of the University of Missouri - Combined January 1, 2016 through December 31, 2016

Centralising to a 7 day stroke stroke service in Greater Manchester - lessons learnt

Healthier Communities. Effective Governance

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Screening Division of Public Health Wales BTW Annual Statistical Report

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

National Institute for Communicable Diseases -- Weekly Surveillance Report --

Cancer Waiting Times in NHSScotland

South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation

Trust Board Meeting in Public: Wednesday 11 July 2018 TB

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

GSK Medicine: Study No.: Title: Rationale: Study Period Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source:

NHS Bowel Cancer Screening Programme in Merseyside: Till Receipt Awareness Campaign in 2014

Cancer Waiting Times in NHSScotland

McLean ebasis plus TM

Education around PML risk and monitoring at NHNN Queen Square MS Centre

FFT and Patient Insight for Improvement. Marie Allen Head of Service User and Carer Experience

Cancer Waiting Times in NHSScotland

Curators of the University of Missouri - Combined January 01, 2013 through December 31, 2013 Cost Management Report

Swine Flu Pandemic Weekly Report Thursday 22 October 2009

The Greater Manchester Stroke Operational Delivery Network

Public Health Agency NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN QUALITY ASSURANCE REFERENCE CENTRE

Aneurin Bevan Health Board. Screening Programmes

Acupuncture, Counselling and Usual care for Depression (ACUDep trial): Dr Stewart Richmond

Kansas EMS Naloxone (Narcan) Administration

Understanding the Role of Palliative Care in the Treatment of Cancer Patients

Sleep Market Panel. Results for June 2015

MEDICAL POLICY SUBJECT: MAMMOGRAPHY: COMPUTER- AIDED DETECTION (CAD) POLICY NUMBER: CATEGORY: Technology Assessment

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Faster Cancer Treatment: Using a health target as the platform for delivering sustainable system changes

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Highland NHS Board 6 October 2015 Item 5.1 NEW VACCINATION PROGRAMMES

Texas Vendor Drug Program Specialty Drug List Process. February 2019

KPI s September Megan Boivin Operations Manager 15 October KPI s HAC report 18/10/2007 Operations Manager : Megan Boivin

Referral to treatment (RTT) waiting times statistics for consultant-led elective care 2014 Annual Report

One Palliative Care Annual Report

Poster Session HRT1317 Innovation Awards November 2013 Brisbane

2.3 Invasive Group A Streptococcal Disease

Making Healthy Normal

Surgical Site Infection (SSI) Surveillance Update (with special reference to Colorectal Surgeries)

Trust Board of Directors Public. Denise Gale. For Assurance and Information NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE NOT APPLICABLE

Consultant-led Referral to Treatment (RTT) waiting times collection timetable: outcome of consultation

BJA Performance Measures

Aneurin Bevan Health Board. Quarterly Infection Control Report

Interpretability of Sudden Concept Drift in Medical Informatics Domain

Colorectal Cancer- QI process and clinic success: A Case Study at Atascosa Health Center

8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )

7.14 Young Person and Adult (YPA) Screening Programmes

East London Community Kidney Service

North Dakota Board of Pharmacy

plasma MATCH Andrew Wardley,

Quality & Safety Committee Date: 22 June 2016 Agenda item: 4.4

NHS Cervical Screening Programme in Kingston and Richmond ANNUAL REPORT

Making Healthy Normal

ESPA Directorate KPI Report: Quarter 1,

Llwchwr Cluster Public Health Profile V1

Dementia Content Report January Produced By The NHS Choices Reporting Team

Shingles (herpes zoster) vaccine programme in Scotland for 2016/17

NORTHERN HEALTH AND SOCIAL CARE TRUST. Waiting Times Summary Report

Dementia Content Report May Produced By The NHS Choices Reporting Team

Global Fund Approach to Health System Strengthening

EDINBURGH HEALTHCARE NHS TRUST. 4 Edinburgh Healthcare NHS Trust Printed Material,

CERVICAL SCREENING WALES CERVICAL SCREENING PROGRAMME, WALES: 2001/02

Emergency Department Boarding of Psychiatric Patients in Oregon

Improving Opioid Agonist Therapies with System Change

Colorado State Innovation Model (SIM) Clinical Quality Measures (CQMs) Reporting Schedules

POPULATION BASED NATIONAL SCREENING PROGRAMMES IN POWYS TEACHING HEALTH BOARD

Transcription:

Breast Test Wales Screening Division Public Health Wales Programme Level Agreement with Welsh Government Quarterly Report October - December

Breast Test Wales - Quarterly Report October - December Service Description Breast Test Wales is responsible for the NHS breast screening programme in Wales. The invited group is women aged 5 to 7. The aim of the breast screening programme is to reduce morbidity and mortality from breast cancer. Summary Indicator Name Jan - Mar Apr - Jun Jul - Sep Oct-Dec BTW-1 Uptake - of invited women who attend for screening >=7% 77.3% 72.3% 72.9% 72.8% BTW-2 BTW-3 BTW-4 Coverage - of resident and eligible women who attend for screening within the previous 3 years Invasive cancer detection rate (prevalent screen) Invasive cancer detection rate (incident screen) >=7% 74.6% >=2.7 per 1 scr >=3.1 per 1 scr 6.4 4.4 5.8 6.6 6.6 7.8 7.2 6.2 BTW-5 Normal results sent within 2 weeks of screen >=9% 87.7% 63.5% 58.4% 73.9% BTW-6 Assessment invitations given within 3 weeks of screen >=9% 39.6% 31.4% 38.8% 33.3% BTW-7 Waiting times for therapeutic surgery, admissions within 31 days >=95% 91.3% 87.3% 86.9% 95.2% BTW-8 Assessment recall rate (all women) No 4.6% 5.% 5.1% 5.% BTW-9A Round length (invited within 36 months) >=9% 85.% 84.2% 73.1% 46.4% BTW-9B Round length (invited within 38 months) >=9%* 98.5% 98.4% 91.8% 85.4% BTW-1 Screening activity - Number of women screened No 28422 2571 21494 13575 Comments BTW-1 BTW-2 BTW-3 BTW-4 BTW-5 BTW-6 BTW-7 BTW-8 BTW-9A BTW-9B BTW-1 No comments at this time /11 figures given as only annual figures are available due to external information reporting requirement. No comments at this time No comments at this time Improvements to the results handiling process should mean that more results are provided within 2 weeks in future. This is a challenging UK target for Wales due to the geographical consideration which is given when arranging assessment appointments. A review of assessment clinic arrangements is due to commence in early 212. Meeting this target is not within the control of Breast Test Wales but is monitored to indicate the timeliness of the breast cancer treatment for women diagnosed via breast screening. No comments at this time This target has not been achived due to the delays which are an inevitable consquence of the Digital Mamography Project Implementation in /212. Steps are in place to minimise the delay but the screening round will continue to elongate throughout 212. See above Screening activity has been reduced in the last 2 quarters of as an inevitable consequence of the Digital Mamography Project Implementation.

BTW-1: Uptake October - December The percentage of invited women who attend for screening >=7% of invited women to attend for screening BTW-1: Uptake 1 95 9 85 8 75 7 65 6 55 5 BTW-1: Uptake 69.8 8.3 81.7 74. 73.6 67.8 71. 71.2 76.4 74.4 73.2 7.9 73.7 75.2 76.8 76.7 68. 76.3 69.9 75.2 71.3 77.7 75.1 76. 76.5 79.8 72.6 76.6 74. 67.5 69.4 75.7 76.8 72. 8.6 74.4 Note: includes women who attend for screening within 6 months of the invitation therefore report month of December relates to those invited in June

BTW-2: Coverage October - December The percentage of resident and eligible women who attend for screening within the previous 3 years >=7% of eligible women to attend for screening BTW-2: Coverage 1 95 9 85 8 75 7 65 Coverage 6 55 5 26/7 27/8 28/9 /1 /11 BTW-2: Coverage 26/7 27/8 28/9 /1 /11 Coverage 75. 75.1 73.7 73.8 74.6 Note: only annual figures available

October - December BTW-3: Invasive Cancer Detection Rate (Prevalent Screen) The rate of invasive cancers detected in eligible women invited and screened for the first time >=2.7 invasive cancers detected per 1 women screened BTW-3: Invasive Cancer Detection Rate (Prevalent Screen) 1 Rate per 1 women screened 9 8 7 6 5 4 3 2 1 Jan-Mar Apr-Jun Jul-Sep Oct-Dec BTW-3: Invasive Cancer Detection Rate (Prevalent Screen) Jan-Mar Apr-Jun Jul-Sep Oct-Dec 6.4 4.4 5.8 6.6 6.5 5.2 5.2 7.4 8.1 5.3 7.1 4. Note: includes women who attend for screening within 6 months of the invitation therefore report month of December relates to those invited in June

October - December BTW-4: Invasive Cancer Detection Rate (Incident Screen) The rate of invasive cancers detected in eligible women invited and screened at subsequent visits >=3.1 invasive cancers detected per 1 women screened BTW-4: Invasive Cancer Detection Rate (Incident Screen) 1 Rate per 1 women screened 9 8 7 6 5 4 3 2 1 Jan-Mar Apr-Jun Jul-Sep Oct-Dec BTW-4: Invasive Cancer Detection Rate (Incident Screen) Jan-Mar Apr-Jun Jul-Sep Oct-Dec 6.6 7.8 7.2 6.2 7.3 6.1 7.1 8.1 6.7 6.2 6.6 6.4 Note: includes women who attend for screening within 6 months of the invitation therefore report month of December relates to those invited in June

October - December BTW-5: Normal Results Sent Within 2 Weeks of Screen The percentage of women who are sent their normal result within 2 weeks >=9% of normal results sent within 2 weeks of screen BTW-5: Normal Results Sent Within 2 Weeks of Screen 1 9 8 7 6 5 4 3 2 1 BTW-5: Normal Results Sent Within 2 Weeks of Screen 9.8 83.7 88.5 43.2 62.8 84.2 49.9 51.6 78.4 61.1 75.6 89.1 89.3 85.4 68. 46.8 4. 36.4 33.8 59.3 5.2 37.8 43.4 44.6 85. 75.4 74.1 39.5 54.2 85.7 92.4 82. 63.6 5.1 65.7 43.2

BTW-6: Assessment Invitations Given Within 3 Weeks of Screen October - December Number of women requiring assessment offered an appointment within 3 weeks of screen >=9% of assessment invitations given within 3 weeks of screen BTW-6: Assessment Invitations Given Within 3 Weeks of Screen 1 9 8 7 6 5 4 3 2 1 BTW-6: Assessment Invitations Given Within 3 Weeks of Screen 2.1 63.7 37.8 5. 24.6 24.1 39.6 36.8 41. 3. 34.9 36.5 2.9 63. 66.7 51.2 31.6 31.4 25.5 16.2 24.2 28.1 2.4 3.1 28.9 88.9 43.4 5.1 38.2 42.8 82.2 73.9 75.4 44.9 42.1 41.3

BTW-7: Waiting Times for Therapeutic Surgery, Admissions Within 31 Days October - December of women who are admitted for therapeutic surgery within 31 days of receiving result >=95% of women admitted within 31 days of date of result BTW-7: Waiting times for Therapeutic Surgery, Admissions Within 31 Days 1 95 9 85 8 75 7 65 6 55 5 Jan-Mar Apr-Jun Jul-Sep Oct-Dec BTW-7: Waiting Times for Therapeutic Surgery, Admissions Within 31 Days Jan-Mar Apr-Jun Jul-Sep Oct-Dec 91.3 87.3 86.9 95.2 9.6 83.6 93.3 92.3 89.3 88.9 96.7 97.

October - December BTW-8: Assessment Recall Rate (All Women) of women who attend for screening who are recalled for assessment No exists but the rate is monitored by all breast screening programmes and trends investigated. BTW-8: Assessment Recall Rate (All Women) 1 9 8 7 6 5 4 3 2 1 BTW-8: Assessment Recall Rate (All Women) 5.2 4.1 4.5 5. 5. 4.8 5. 5.5 4.9 5.2 5.4 4.5 4.6 4.7 5.1 4.4 5.1 4.5 5.4 4.8 4.9 5.4 5.5 5. 4.9 4.8 5.4 4.7 4.2 4.4 5. 4.4 4.6 5.1 4.4 4.8 Note: includes women who attend for screening within 6 months of the invitation therefore report month of December relates to those invited in June

BTW-9A: Round Length (36 months) October - December The percentage of women whose first offered appointment is within 36 months of their previous screen >=9% of women given an appointment within 36 months of their previous screen BTW-9A: Round Length (36 months) 1 9 8 7 6 5 4 3 2 1 BTW-9A: Round Length (36 months) 87.8 84.2 82.7 83.3 82.5 86.8 77.9 78.2 61.3 55.6 49.6 24.2 74.8 77.3 74.1 72.4 7.7 75.2 82. 75.4 79.3 83.1 83.9 83.9 72.5 56.8 53.2 61.3 53.5 56.8 6.3 66.2 62.9 73.5 82.5 74.6

BTW-9B: Round Length (38 months) October - December The percentage of women whose first offered appointment is within 38 months of their previous screen No (but 9% used for comparison purposes) BTW-9B: Round Length (38 months) 1 9 8 7 6 5 4 3 2 1 BTW-9B: Round Length (38 months) 98.1 98. 99.5 98.3 98. 98.8 92.2 97.8 84.9 85.9 9.6 73.9 85. 85.8 91.9 96.1 96.5 95.7 98. 97.7 98.1 98.4 98.5 99.1 83.6 75.9 71.2 74.8 73.1 76.5 76.4 78.2 7.4 86.8 9.6 84.5

BTW-1: Screening Activity October - December Number of screening tests undertaken No BTW-1: Screening Activity Number of women screened 12 11 1 9 8 7 6 5 4 3 2 1 BTW-1: Screening Activity 959 929 9884 8237 8978 8486 8656 6615 6223 4971 5646 2958 7937 9156 11144 9767 9356 1371 851 92 1316 977 9735 659 8634 854 1398 185 8998 9776 965 8623 1211 1237 9417 6541